| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 51.01 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Schizophrenia (SCZ) patients are reported to present significant abnormalities in lipid and glucose metabolism, that increase the risk for cardiovascular disease and diabetes, possibly induced by antipsychotic therapy (APT) and lifestyle.
Description
Keywords
Schizophrenia Antipsychotic
Citation
Amorim, M., Moreira, A., Condeco, J., Monteiro, P., Marques, A., & Summavielle, T. (2012). Antipsychotic therapy and biochemical laboratory profile characterization of a sample of patients diagnosed with schizophrenia. European Psychiatry, 27, 1. https://doi.org/10.1016/S0924-9338(12)75368-3
Publisher
Elsevier